Lannett Company Inc. (LCI)
Россия
  • Россия
  • Украина

Lannett Company Inc. (LCI)

Contact Details

9000 State Rd, Philadelphia, Pennsylvania, USA 19136-1615
(215) 333-9000
9000 State Rd, Philadelphia, Pennsylvania, USA 19136-1615

General Information

Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies.

Contact Information

Phone(215) 333-9000
Fax(215) 333-9004
Website 1http://www.lannett.com
Website 2http://www.lannetttest.com
LinkedInLinkedIn
Thomson Reuters PermID4295914027

Executives

NamePositionTotal Annual CompensationYearPercent Change in Compensation
CEO$1,245,7662015-60.3%
President$299,5972015
COO$546,8542015-61.0%
CFO, Divisional Vice President and Treasurer$640,6622015-63.6%
Divisional Senior VP$653,0562015-51.6%
Other Executive Officer and Divisional Vice President$944,979201486.6%

Government Contracts

Largest Contracts

AgencyProduct or ServiceSigned DateObligation Amount
Department of Veterans AffairsDrugs and Biologicals, Laboratory Equipment and Supplies, Medical and Surgical Instruments, Equipment and Supplies, Miscellaneous Electrical and Electronic ComponentsJuly 15, 2001$2,561.53

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$407 million
Employees502

Ownership

Ticker SymbolLCI
ExchangeNew York Stock Exchange (NYSE)
Year Founded1942

Stocks

Previous Close18.22
Open17.78
Bid17.80 x 100
Ask17.83 x 300
Day`s Range17.74 - 18.05
52-Week Range17.23 - 71.15
Average Volume (1M)1,436,091
Forward P/E5.91x
Trailing P/E4.92x
Beta1.82x
Market Cap.$688.48 Million

Financials

Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue127,059106,43399,27699,352
Cost of Revenue55,41429,00627,32623,714
Gross Profit71,64577,42771,95075,638
Research Development9,0696,5286,9849,159
Selling General and Administrative14,66615,53616,01712,204
Depreciation and Amortization----
Other Operating Expenses17,5853,942(2,069)-
Total Operating Expenses96,73455,01248,25845,077
Other Income/Expenses Net----
Earnings Before Interest and Taxes30,32551,42151,01854,275
Interest Expense11,77260888
Income Before Tax19,49850,25151,18354,233
Income Tax Expense5,95817,05517,22217,973
Minority Interest----
Net Income from Continuing Ops13,54033,19633,96136,260
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items(20)(15)(18)(27)
Net Income13,52033,18133,94336,233
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares13,52033,18133,94336,233